Valuation: Haemonetics Corporation

Market Cap 341.39Cr 298.95Cr 275.93Cr 257.49Cr 484.43Cr 32TCr 493.56Cr 3.31TCr 1.28TCr 16TCr 1.28TCr 1.25TCr 56TCr P/E 2027 *
19x
P/E 2028 * 16.8x
Enterprise Value 408.64Cr 357.83Cr 330.28Cr 308.21Cr 579.86Cr 39TCr 590.78Cr 3.96TCr 1.54TCr 19TCr 1.54TCr 1.5TCr 66TCr EV / Sales 2027 *
2.92x
EV / Sales 2028 * 2.58x
Free-Float
98.75%
Yield 2027 *
2.67%
Yield 2028 * -
1 day-0.16%
1 week+3.41%
Current month+10.60%
1 month+10.60%
3 months+38.79%
6 months-6.87%
Current year-6.43%
1 week 72.04
Extreme 72.04
79.82
1 month 64.79
Extreme 64.79
81.99
Current year 51
Extreme 51
86.11
1 year 47.32
Extreme 47.315
87.32
3 years 47.32
Extreme 47.315
97.97
5 years 43.5
Extreme 43.5
97.97
10 years 28.84
Extreme 28.8417
142.11
Manager TitleAgeSince
Chief Executive Officer 62 16/05/2016
Director of Finance/CFO 55 11/04/2022
Chief Operating Officer 56 01/04/2025
Director TitleAgeSince
Director/Board Member 73 01/01/2006
Director/Board Member 71 23/07/2014
Director/Board Member 62 16/05/2016
Date Insider Type Main position Quantity % Market Cap.
05/06Tax

VP, Chief Accounting Officer

-259 0.0006%
05/06Tax

Head of Human Resources

-313 0.0007%
15/05Tax

General Counsel

-31,337 0.0674%
Change 5-day change 1-year change 3-year change Capi.($)
-0.16%+3.41%+1.63%-11.60% 341.39Cr
-2.12%+3.31%-32.48%-15.72% 16TCr
-3.34%-1.31%-9.06%-9.84% 10TCr
+0.47%+4.31%-5.49%+48.53% 5.48TCr
+0.56%-3.80%+53.05%+53.64% 5.33TCr
-2.49%+7.55%-11.43%-41.91% 4.28TCr
-0.43%+13.63% - - 3.35TCr
-3.76%-2.49%-21.99%-47.36% 2.7TCr
+1.22%+8.88%+64.02%-4.87% 2.51TCr
-1.25%+5.07%-11.82%-4.72% 2.08TCr
Average -1.13%+5.13%+2.94%-3.76% 5.26TCr
Weighted average by Cap. -1.62%+4.64%-6.85%-2.78%

Financials

2027 *2028 *
Net sales 140.04Cr 122.63Cr 113.19Cr 105.63Cr 198.72Cr 13TCr 202.47Cr 1.36TCr 526.69Cr 6.53TCr 526.15Cr 514.31Cr 23TCr 147.42Cr 129.09Cr 119.15Cr 111.19Cr 209.19Cr 14TCr 213.13Cr 1.43TCr 554.43Cr 6.88TCr 553.85Cr 541.39Cr 24TCr
Net income 17Cr 15Cr 14Cr 13Cr 25Cr 1.64TCr 25Cr 167.92Cr 65Cr 807.97Cr 65Cr 64Cr 2.82TCr 20Cr 18Cr 16Cr 15Cr 29Cr 1.92TCr 29Cr 196.87Cr 76Cr 947.26Cr 76Cr 75Cr 3.3TCr
Net Debt 67Cr 59Cr 54Cr 51Cr 95Cr 6.36TCr 97Cr 651.96Cr 252.91Cr 3.14TCr 252.64Cr 246.96Cr 11TCr 38Cr 34Cr 31Cr 29Cr 55Cr 3.64TCr 56Cr 373.07Cr 144.72Cr 1.8TCr 144.57Cr 141.32Cr 6.26TCr
Logo Haemonetics Corporation
Haemonetics Corporation is a medical technology company. Its solutions address critical medical needs, which includes a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers, and products to enable blood centers to collect in-demand blood components. Its Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. Its Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies (Hemostasis Management, Cell Salvage and Transfusion Management products). It also offers solutions for structural heart and endovascular procedures.
Employees
3,009
Date Price Change Volume
30/26/30 $75.00 -0.16% 5,53,888
29/26/29 $75.12 -2.81% 6,12,908
26/26/26 $77.29 -0.43% 16,08,297
25/26/25 $77.62 +6.52% 7,46,058
24/26/24 $72.87 +0.12% 5,23,943
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
75.00USD
Average target price
85.20USD
Spread / Average Target
+13.60%

Quarterly revenue - Rate of surprise